Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ)
CNY 3.83
(-1.03%)
CNY 3.83
(-1.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 9.53 Billion | 7.52 Billion | 4.17 Billion | 21.42 Billion | 28.59 Billion | 14.98 Billion |
| Net Income | -1.28 Billion | 510.61 Million | 880.21 Million | 1.11 Billion | 2.91 Billion | 2.37 Billion |
| Depreciation & Amortization | 152.37 Million | 147.27 Million | 133.93 Million | 63.66 Million | 79.16 Million | 1.12 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 14.61 Billion | 16.07 Billion | 11.93 Billion | 30.7 Billion | 35.36 Billion | -26.78 Billion |
| Other non-cash items | 791.55 Million | -9.2 Billion | -8.77 Billion | -10.46 Billion | -9.75 Billion | 38.26 Billion |
| Investing Cash Flow | -3.64 Billion | -15.61 Billion | -15.38 Billion | -7.68 Billion | -35.04 Billion | -9.17 Billion |
| Investments in PPE | -67.52 Million | -135.06 Million | -287.13 Million | -308.41 Million | -717.09 Million | -274.67 Million |
| Acquisitions | 1.62 Million | 16.95 Million | 1.78 Million | -3.44 Billion | 258.83 Million | 334.25 Million |
| Investment purchases | -161.93 Billion | -97.62 Billion | -109.75 Billion | -71.49 Billion | -123.08 Billion | -77.37 Billion |
| Sales/Maturities of investments | 158.52 Billion | 84.12 Billion | 94.71 Billion | 67.78 Billion | 88.94 Billion | 68.03 Billion |
| Other Investing Activities | -166.78 Million | -1.99 Billion | -62.2 Million | -222.19 Million | -445.85 Million | 102.77 Million |
| Financing Cash Flow | -4.07 Billion | 11.07 Billion | 7.62 Billion | 172.58 Million | 1.12 Billion | 1.34 Billion |
| Debt repayment | -258.25 Million | -11.76 Billion | -7.7 Billion | -854.06 Million | -102.75 Million | -288 Million |
| Dividends payments | -543.46 Million | -24.7 Million | -49.4 Million | -494.06 Million | -148.21 Million | -311.64 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | -2.26 Million |
| Other Financing Activities | -2.66 Billion | 23.54 Billion | 15.7 Billion | 1.66 Billion | 1.47 Billion | 1.94 Billion |
| Accounts receivables | -130.19 Million | 1.64 Billion | -609.08 Million | -279.52 Million | 1.54 Billion | -14.61 Billion |
| Accounts payables | - | -1.64 Billion | 609.08 Million | 279.52 Million | -1.54 Billion | - |
| Inventory | -2.12 Billion | -279.55 Million | 471.05 Million | -188.32 Million | 177.58 Million | 120.54 Million |
| Other working capital | 17.48 Billion | 16.35 Billion | 11.46 Billion | 30.89 Billion | 35.18 Billion | -26.91 Billion |
| Cash at beginning of period | 26.3 Billion | 23.25 Billion | 26.85 Billion | 12.97 Billion | 18.3 Billion | 11.15 Billion |
| Cash at end of period | 28.14 Billion | 26.3 Billion | 23.25 Billion | 26.85 Billion | 12.97 Billion | 18.3 Billion |
| Capital Expenditure | -67.52 Million | -135.06 Million | -287.13 Million | -308.41 Million | -717.09 Million | -274.67 Million |
| Effect of forex changes on cash | 20.46 Million | 72.01 Million | -15.2 Million | -33.9 Million | -1.35 Million | 1.59 Million |
| Net cash flow / Change in cash | 1.83 Billion | 3.05 Billion | -3.6 Billion | 13.87 Billion | -5.32 Billion | 7.14 Billion |
| Free Cash Flow | 9.46 Billion | 7.38 Billion | 3.88 Billion | 21.11 Billion | 27.88 Billion | 14.7 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 31.91 Million | -275.14 Million | -89.87 Million | -438.78 Million | -1.28 Billion | -25.59 Million |
| Depreciation & Amortization | - | 72.67 Million | - | 152.37 Million | 152.37 Million | -73.93 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -14.49 Billion | - | 15.22 Billion | 14.61 Billion | 45.49 Million |
| Other non-cash items | 1.23 Billion | 4.16 Billion | -18.38 Billion | 438.78 Million | 791.55 Million | 330.09 Million |
| Investing Cash Flow | -3.29 Billion | -4.73 Billion | 14.82 Billion | 8.66 Billion | -3.64 Billion | -9.45 Billion |
| Investments in PPE | -12.03 Million | -9.08 Million | -2.75 Million | -44.36 Million | -67.52 Million | -10.5 Million |
| Acquisitions | 81.57 Thousand | 419.43 Thousand | 62.59 Thousand | 425 Thousand | 1.62 Million | 55.89 Thousand |
| Investment purchases | -29.61 Billion | -25.65 Billion | -26.66 Billion | -36.98 Billion | -161.93 Billion | -51.31 Billion |
| Sales/Maturities of investments | 26.06 Billion | 21.26 Billion | 41.57 Billion | 45.77 Billion | 158.52 Billion | 41.87 Billion |
| Other Investing Activities | 268.45 Million | -342.12 Million | -77.19 Million | -84.16 Million | -166.78 Million | -9.39 Million |
| Financing Cash Flow | 813.1 Million | -7.41 Billion | -1.72 Billion | -300.85 Million | -4.07 Billion | -3.33 Billion |
| Debt repayment | -1.04 Billion | -5.65 Billion | -1.66 Billion | -68.18 Million | -258.25 Million | -3.09 Billion |
| Dividends payments | -232.94 Million | -52.29 Million | -171 Million | -543.46 Million | -543.46 Million | -304.03 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 1.04 Billion | -5.65 Billion | -1.55 Billion | -7.17 Million | -2.66 Billion | 68.69 Million |
| Accounts receivables | - | -312.61 Million | - | -130.19 Million | -130.19 Million | 45.21 Million |
| Accounts payables | - | - | - | - | - | 18.82 Billion |
| Inventory | - | -225.09 Million | - | -2.12 Billion | -2.12 Billion | 279.22 Thousand |
| Other working capital | - | -13.96 Billion | - | 17.48 Billion | 17.48 Billion | -18.82 Billion |
| Cash at beginning of period | 11 Billion | 21.18 Billion | 28.14 Billion | 25.63 Billion | 26.3 Billion | 38.14 Billion |
| Cash at end of period | 8.33 Billion | 11 Billion | 21.18 Billion | 28.14 Billion | 28.14 Billion | 25.63 Billion |
| Capital Expenditure | -12.03 Million | -9.08 Million | -2.75 Million | -44.36 Million | -67.52 Million | -10.5 Million |
| Effect of forex changes on cash | -2.83 Million | -6.52 Million | -237.19 Thousand | -1.54 Million | 20.46 Million | -2.56 Million |
| Net cash flow / Change in cash | -2.67 Billion | -10.17 Billion | -6.95 Billion | 2.51 Billion | 1.83 Billion | -12.51 Billion |
| Free Cash Flow | 1.25 Billion | 3.88 Billion | -18.47 Billion | -5.89 Billion | 9.46 Billion | 265.55 Million |
IMAS
1709
5214
TGGI
ROG
6874